Skip to Content

New-Onset Type 1 Diabetes in Adults

A Phase III, Multinational, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study to Investigate the Clinical Efficacy and Safety of DiaPep277® in Newly Diagnosed Type 1 Diabetes Subjects

IRB Protocol Number

All Other Trials

  • Diabetes
  • Drugs (Pharmacology)
Elizabeth Cohlmia at 303-724-3974
Eligibility and Other Participant Information
For more information, please view the study's poster.